| Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression R Bellucci, A Martin, D Bommarito, K Wang, SH Hansen, GJ Freeman, ... Oncoimmunology 4 (6), e1008824, 2015 | 338 | 2015 |
| Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1 D Bommarito, C Hall, LS Taams, VM Corrigall Clinical & Experimental Immunology 188 (3), 455-466, 2017 | 86 | 2017 |
| Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway D Bommarito, A Martin, E Forcade, MD Nastke, J Ritz, R Bellucci Cancer Immunology, Immunotherapy 65 (3), 355-366, 2016 | 19 | 2016 |
| JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression R Bellucci, A Martin, D Bommarito, KS Wang, GJ Freeman, J Ritz Blood 122 (21), 3472-3472, 2013 | 3 | 2013 |
| The PD-1/PD-L1 axis is modulated by pro-inflammatory cytokines D Bommarito, C Hall, LS Taams, VM Corrigall Annals of the Rheumatic Diseases 75 (Suppl 1), A16-A16, 2016 | 2 | 2016 |
| Enhancement of Tumor Cell Susceptibility to NK Cell Activity Through Inhibition of the PI3K Signaling Pathway. D Bommarito, A Martin, MD Nastke, J Ritz, R Bellucci Blood 120 (21), 2152-2152, 2012 | 2 | 2012 |
| JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-gamma) Pathway R Bellucci, A Martin, M Buren, HN Nguyen, D Bommarito, J Ritz Blood 118 (21), 1694-1694, 2011 | 1 | 2011 |
| The role of the PD-L1/PD-1/PI3K axis in inflammatory arthritis D Bommarito, C Hall, LS Taams, VM Corrigall Immunology 143, 72-72, 2014 | | 2014 |
| Targeting the Interferon-γ (IFN-γ) Pathway to Enhance Susceptibility of Multiple Myeloma Tumor Cells to NK Cell Lysis R Bellucci, A Martin, D Bommarito, J Ritz Blood 120 (21), 4013-4013, 2012 | | 2012 |
